Leukaemia stem cells and the evolution of cancer-stem-cell research

被引：464

作者：

Huntly, BJP ^{[1
]}

Gilliland, DG

机构：

[1] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA

来源：

NATURE REVIEWS CANCER | 2005年 / 5卷 / 04期

关键词：

D O I：

10.1038/nrc1592

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Many cancers seem to depend on a small population of 'cancer stem cells' for their continued growth and propagation. The leukaemia stem cell (LSC) was the first such cell to be described. The origins of these cells are controversial, and their biology-like that of their normal-tissue counterpart, the haematopoietic stem cell (HSC)-is still not fully elucidated. However, the LSC is likely to be the most crucial target in the treatment of leukaemias, and a thorough understanding of its biology-particularly of how the LSC differs from the HSC-might allow it to be selectively targeted, improving therapeutic outcome.

引用

页码：311 / 321

页数：11

共 126 条

[1] Prospective identification of tumorigenic breast cancer cells [J].

Al-Hajj, M ;

Wicha, MS ;

Benito-Hernandez, A ;

Morrison, SJ ;

Clarke, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988

[2] HOXB4-induced expansion of adult hematopoietic stem cells ex vivo [J].

Antonchuk, J ;

Sauvageau, G ;

Humphries, RK .

CELL, 2002, 109 (01) :39-45

[3] MLL-rearranged leukemias:: Insights from gene expression profiling [J].

Armstrong, SA ;

Golub, TR ;

Korsmeyer, SJ .

SEMINARS IN HEMATOLOGY, 2003, 40 (04) :268-273

[4] Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1 [J].

Aster, JC ;

Xu, LW ;

Karnell, FG ;

Patriub, V ;

Pui, JC ;

Pear, WS .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7505-7515

[5] Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins [J].

Ayton, PM ;

Cleary, ML .

ONCOGENE, 2001, 20 (40) :5695-5707

[6]

BECKWITH J B, 1990, Pediatric Pathology, V10, P1

[7]

Berry LW, 1997, DEVELOPMENT, V124, P925

[8] Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo [J].

Blair, A ;

Hogge, DE ;

Ailles, LE ;

Lansdorp, PM ;

Sutherland, HJ .

BLOOD, 1997, 89 (09) :3104-3112

[9] Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR- [J].

Blair, A ;

Hogge, DE ;

Sutherland, HJ .

BLOOD, 1998, 92 (11) :4325-4335

[10] Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD 117) [J].

Blair, A ;

Sutherland, HJ .

EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :660-671

← 1 2 3 4 5 6 7 8 9 10 →